When stratified by age, pediatric FTC cases displayed a markedly higher prevalence of DICER1 mutations (44.4% vs. 4.6% in adults), supporting previous findings that emphasize the distinct molecular drivers in pediatric thyroid tumors [18,25,26]. This evidence concerns the gene DICER1 and thyroid cancer, nonmedullary, 2.